Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
28 12월 2019 - 4:12AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION
OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES
EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS
UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-36819
Spark Therapeutics, Inc.
(Exact name of registrant as specified
in its charter)
3737 Market Street
Suite 1300
Philadelphia, Pennsylvania 19104
(888) 772-7560
(Address, including zip code, and telephone
number, including area code, of registrant’s principal executive offices)
Common Stock, par value $0.001 per share
(Title of each class of securities covered
by this Form)
None
(Titles of all other classes of securities
for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate
rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
|
|
Rule 12g-4(a)(1)
|
|
☒
|
|
Rule 12g-4(a)(2)
|
|
☐
|
|
Rule 12h-3(b)(1)(i)
|
|
☒
|
|
Rule 12h-3(b)(1)(ii)
|
|
☐
|
|
Rule 15d-6
|
|
☐
|
|
Rule 15d-22(b)
|
|
☐
|
Approximate number of holders of record as of the certification
or notice date: One.
Pursuant to the requirements of the Securities Exchange Act
of 1934, Spark Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized
person.
Date: December 27, 2019
|
|
BY:
|
/s/ Joseph W. La Barge
|
|
|
|
|
Name: Joseph W. La Barge
|
|
|
|
|
Title: Chief Legal Officer
|
|
Onconetix (NASDAQ:ONCE)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Onconetix (NASDAQ:ONCE)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
